Effectiveness and safety of AI-driven closed-loop systems in diabetes management: a systematic review and meta-analysis
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Multiple reviews and methodological studies show that machine‑learning and deep‑learning models improve predictive accuracy for hypoglycemia, hyperglycemia, and overall glycemic variability compared with traditional approaches, laying the groundwork for data‑driven decision support and ultimately, closed‑loop systems in T2D [47–49].”
From Digital Management of Early-Onset Type 2 Diabetes: Empowerment, Challenges, and Future Outlook (2026) · cites this paper as [49]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sun, H., Saeedi, P., Karuranga, S., Pinkepank, M., Ogurtsova, K., Duncan, B. B., Stein, C., Basit, A., Chan, J. C. N., Mbanya, J. C., et al. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.109119 · Cited by 10,123
Luo, D., Wan, X., Liu, J., & Tong, T. (2018) · Statistical Methods in Medical Research · doi:10.1177/0962280216669183 · Cited by 4,066 · cited 1×
“For data presented as median values with interquartile ranges (IQR), we estimated the mean and standard deviation using validated meth-ods for skewed distributions [51, 52].”
Genetics of diabetes mellitus and diabetes complications
Cole, J. B., & Florez, J. C. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-020-0278-5 · Cited by 1,797
Komorowski, M., Celi, L. A., Badawi, O., Gordon, A. C., & Faisal, A. A. (2018) · Nature Medicine · doi:10.1038/s41591-018-0213-5 · Cited by 1,290 · cited 1×
“For clinicians, AI can analyze large-scale subject datasets, generating retrospective insights that assist in optimizing treatment strategies [20, 21].”
Zhou, B., Rayner, A. W., Gregg, E. W., Sheffer, K. E., Carrillo-Larco, R. M., Bennett, J. E., Shaw, J. E., Paciorek, C. J., Singleton, R. K., Barradas Pires, A., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)02317-1 · Cited by 1,013
Self-citationArtificial intelligence-enhanced electrocardiography in cardiovascular disease management
Siontis, K. C., Noseworthy, P. A., Attia, Z. I., & Friedman, P. A. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-020-00503-2 · Cited by 914
6. Glycemic Targets: Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s006 · Cited by 744 · cited 1×
“TAR > 180 mg/dL is often due to postprandial hyperglycemia, and prolonged levels at this threshold increase the risk of cardiovascular disease [66–68].”
A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes
Breton, M. D., Kanapka, L. G., Beck, R. W., Ekhlaspour, L., Forlenza, G. P., Cengiz, E., Schoelwer, M., Ruedy, K. J., Jost, E., Carria, L., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2004736 · Cited by 455
Phillip, M., Nimri, R., Bergenstal, R. M., Barnard-Kelly, K., Danne, T., Hovorka, R., Kovatchev, B. P., Messer, L. H., Parkin, C. G., Ambler-Osborn, L., et al. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnac022 · Cited by 443 · cited 2×
“The application of AI algorithms in automated insulin delivery (AID) and CGM systems [29–31] has created closed-loop systems resembling an artificial pancreas [32, 33].”
Artificial intelligence in diabetes management: Advancements, opportunities, and challenges
Guan, Z., Li, H., Liu, R., Cai, C., Liu, Y., Li, J., Wang, X., Huang, S., Wu, L., Liu, D., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101213 · Cited by 412
Self-citation
Research works printed but not linked: 48
- Wang Y, Zhang P, Shao H, Andes LJ, Imperatore G. Medical costs associated with diabetes complications in medicare beneficiaries aged 65 years or older with type 2 diabetes. Diabetes Care. 2022;45(11):2570–6. · DOI
- Li Y, Liu Y, Liu S, Gao M, Wang W, Chen K, et al. Diabetic vascular diseases: molecular mechanisms and therapeutic strategies. Signal Transduct Target Therapy. 2023;8(1):152. · DOI · Paper page
- ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, et al. 1. Improving care and promoting health in populations: standards of care in diabetes—2023. Diabetes Care. 2023;46(Supplement1):S10–8. · DOI · Paper page
- Kingod N, Grabowski D. In a vigilant state of chronic disruption: how parents with a young child with type 1 diabetes negotiate events and moments of uncertainty. Sociol Health Illn. 2020;42(6):1473–87. · DOI
- Yoon S, Ng JH, Kwan YH, Low LL. Healthcare professionals’ views of factors influencing diabetes self-management and the utility of a mHealth application and its features to support self-care. Front Endocrinol. 2022;13:793473. · DOI
- Perkins BA, Sherr JL, Mathieu C. Type 1 diabetes glycemic management: insulin therapy, glucose monitoring, and automation. Science. 2021;373(6554):522–7. · DOI
- Vargas E, Nandhakumar P, Ding S, Saha T, Wang J. Insulin detection in diabetes mellitus: challenges and new prospects. Nat Reviews Endocrinol. 2023;19(8):487–95. · DOI
- Sperling MA, Laffel LM. Current management of glycemia in children with type 1 diabetes mellitus. N Engl J Med. 2022;386(12):1155–64. · DOI
- Ma J, Fang Y, Yu H, Yi J, Ma Y, Lei P, et al. Recent advances in living algae seeding wound dressing: focusing on diabetic chronic wound healing. Adv Funct Mater. 2024;34(2):2308387. · DOI
- Eghbali-Zarch M, Masoud S. Application of machine learning in affordable and accessible insulin management for type 1 and 2 diabetes: A comprehensive review. Artif Intell Med. 2024:102868. · DOI
- Theodosiou AA, Read RC. Artificial intelligence, machine learning and deep learning: potential resources for the infection clinician. J Infect. 2023. · DOI · Paper page
- Heidari A, Navimipour NJ, Unal M. Applications of ML/DL in the management of smart cities and societies based on new trends in information technologies: A systematic literature review. Sustainable Cities Soc. 2022;85:104089. · DOI · Paper page
- Montaser E, Farhy LS, Rich SS. Enhancing type 1 diabetes immunological risk prediction with continuous glucose monitoring and genetic profiling. Diabetes Technol Ther. 2025;27(4):292–300. · DOI
- Montaser E, Shah VN. Prediction of incident diabetic retinopathy in adults with type 1 diabetes using machine learning approach: an exploratory study. J Diabetes Sci Technol. 2024:19322968241292369. · DOI
- Lee YB, Kim G, Jun JE, Park H, Lee WJ, Hwang YC, et al. An integrated digital health care platform for diabetes management with AI-based dietary management: 48-week results from a randomized controlled trial. Diabetes Care. 2023;46(5):959–66. · DOI · Paper page
- Wang X, Qiu J, Fong DT. The applications of wearable devices in the rehabilitation of ankle injuries: A systematic review and meta-analysis. Med Novel Technol Devices. 2023;17:100210. · DOI
- Tyler NS, Mosquera-Lopez CM, Wilson LM, Dodier RH, Branigan DL, Gabo VB, et al. An artificial intelligence decision support system for the management of type 1 diabetes. Nat Metab. 2020;2(7):612–9. · DOI · Paper page
- Sng GGR, Tung JYM, Lim DYZ, Bee YM. Potential and pitfalls of ChatGPT and natural-language artificial intelligence models for diabetes education. Diabetes Care. 2023;46(5):e103–5. · DOI · Paper page
- Huang HW, You SS, Di Tizio L, Li C, Raftery E, Ehmke C, et al. An automated all-in-one system for carbohydrate tracking, glucose monitoring, and insulin delivery. J Controlled Release. 2022;343:31–42. · DOI
- Mackenzie SC, Sainsbury CA, Wake DJ. Diabetes and artificial intelligence beyond the closed loop: a review of the landscape, promise and challenges. Diabetologia. 2024;67(2):223–35. · DOI
- Nimri R, Phillip M, Kovatchev B. Closed-Loop and artificial Intelligence–Based decision support systems. Diabetes Technol Ther. 2023;25(S1):S–70. · DOI
- Shaw JL, Bannuru RR, Beach L, ElSayed NA, Freckmann G, Füzéry AK et al. Consensus considerations and good practice points for use of continuous glucose monitoring systems in hospital settings. Diabetes Care. 2024:dci240073. · DOI
- Ware J, Allen JM, Boughton CK, Wilinska ME, Hartnell S, Thankamony A, et al. Randomized trial of closed-loop control in very young children with type 1 diabetes. N Engl J Med. 2022;386(3):209–19. · DOI · Paper page
- Al-Sofiani ME, Alharthi S, Albunyan S, Alzaman N, Klonoff DC, Alguwaihes A. A Real-World prospective study of the effectiveness and safety of automated insulin delivery compared with other modalities of type 1 diabetes treatment during ramadan intermittent fasting. Diabetes Care. 2024;47(4):683–91. · DOI
- Fuchs S, Caserto JS, Liu Q, Wang K, Shariati K, Hartquist CM et al. A Glucose-Responsive cannula for automated and Electronics‐Free insulin delivery. Adv Mater. 2024:2403594. · DOI
- Wei Y, Liu C, Liu Y, Zhang Z, Feng Z, Yang X, et al. The association between time in the glucose target range and abnormal ankle-brachial index: a cross-sectional analysis. Cardiovasc Diabetol. 2022;21(1):281. · DOI
- Tauschmann M, Hermann JM, Freiberg C, Papsch M, Thon A, Heidtmann B, et al. Reduction in diabetic ketoacidosis and severe hypoglycemia in pediatric type 1 diabetes during the first year of continuous glucose monitoring: a multicenter analysis of 3,553 subjects from the DPV registry. Diabetes Care. 2020;43(3):e40–2. · DOI · Paper page
- Bogar K, Brensinger CM, Hennessy S, Flory JH, Bell ML, Shi C, et al. Climate change and ambient temperature extremes: association with serious hypoglycemia, diabetic ketoacidosis, and sudden cardiac arrest/ventricular arrhythmia in people with type 2 diabetes. Diabetes Care. 2022;45(11):e171–3. · DOI
- Miyamura K, Nawa N, Nishimura H, Fushimi K, Fujiwara T. Association between heat exposure and hospitalization for diabetic ketoacidosis, hyperosmolar hyperglycemic state, and hypoglycemia in Japan. Environ Int. 2022;167:107410. · DOI
- O’Dea RE, Lagisz M, Jennions MD, Koricheva J, Noble DW, Parker TH, et al. Preferred reporting items for systematic reviews and meta-analyses in ecology and evolutionary biology: a PRISMA extension. Biol Rev. 2021;96(5):1695–722. · DOI · Paper page
- Sanusi AA, Xue Y, McIlwraith C, Howard H, Brocato BE, Casey B, et al. Association of continuous glucose monitoring metrics with pregnancy outcomes in patients with preexisting diabetes. Diabetes Care. 2024;47(1):89–96. · DOI
- Shah VN, Sakamoto C, Pyle L. Optimal sampling duration for continuous glucose monitoring for the Estimation of glycemia risk index. Diabetes Technol Ther. 2023;25(2):140–2. · DOI
- Den Braber N, Vollenbroek-Hutten MM, Westerik KM, Bakker SJ, Navis G, van Beijnum B-JF, et al. Glucose regulation beyond HbA1c in type 2 diabetes treated with insulin: real-world evidence from the DIALECT-2 cohort. Diabetes Care. 2021;44(10):2238–44. · DOI
- Bajaj HS, Ásbjörnsdóttir B, Carstensen L, Laugesen C, Mathieu C, Philis-Tsimikas A, et al. Continuous glucose Monitoring–Based metrics and hypoglycemia duration in insulin-Experienced individuals with Long-standing type 2 diabetes switched from a daily basal insulin to Once-Weekly insulin icodec: post hoc analysis of ONWARDS 2 and ONWARDS 4. Diabetes Care. 2024;47(4):729–38. · DOI
- Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14:135. · DOI · Paper page
- McGrath S, Zhao X, Steele R, Thombs BD, Benedetti A. Estimating the sample mean and standard deviation from commonly reported quantiles in meta-analysis. Stat Methods Med Res. 2020;29(9):2520–37. · DOI · Paper page
- Yang B, Mallett S, Takwoingi Y, Davenport CF, Hyde CJ, Whiting PF, et al. QUADAS-C: a tool for assessing risk of bias in comparative diagnostic accuracy studies. Ann Intern Med. 2021;174(11):1592–9. · DOI · Paper page
- Ma T, Li Q, Song Y, Hua Y. Chronic ankle instability is associated with proprioception deficits: a systematic review and meta-analysis. J Sport Health Sci. 2021;10(2):182–91. · DOI · Paper page
- Ware J, Boughton CK, Allen JM, Wilinska ME, Tauschmann M, Denvir L, et al. Cambridge hybrid closed-loop algorithm in children and adolescents with type 1 diabetes: a multicentre 6-month randomised controlled trial. Lancet Digit Health. 2022;4(4):e245–55. · DOI · Paper page
- Thabit H, Hartnell S, Allen JM, Lake A, Wilinska ME, Ruan Y, et al. Closed-loop insulin delivery in inpatients with type 2 diabetes: a randomised, parallel-group trial. Lancet Diabetes Endocrinol. 2017;5(2):117–24. · DOI · Paper page
- Deshpande S, Pinsker JE, Church MM, Piper M, Andre C, Massa J, et al. Randomized crossover comparison of automated insulin delivery versus conventional therapy using an unlocked smartphone with scheduled pasta and rice meal challenges in the outpatient setting. Diabetes Technol Ther. 2020;22(12):865–74. · DOI
- Laha S, Rajput A, Laha SS, Jadhav R. A concise and systematic review on non-invasive glucose monitoring for potential diabetes management. Biosensors. 2022;12(11):965. · DOI
- Kim MY, Kim G, Park JY, Choi MS, Jun JE, Lee YB, et al. The association between continuous glucose Monitoring-Derived metrics and cardiovascular autonomic neuropathy in outpatients with type 2 diabetes. Diabetes Technol Ther. 2021;23(6):434–42. · DOI · Paper page
- Shah VN, Kanapka LG, Akturk HK, Polsky S, Forlenza GP, Kollman C, et al. Time in range is associated with incident diabetic retinopathy in adults with type 1 diabetes: A longitudinal study. Diabetes Technol Ther. 2024;26(4):246–51. · DOI
- Belsare P, Bartolome A, Stanger C, Prioleau T. Understanding Temporal changes and seasonal variations in glycemic trends using wearable data. Sci Adv. 2023;9(38):eadg2132. · DOI
- Klein KR, Buse JB. The trials and tribulations of determining HbA1c targets for diabetes mellitus. Nat Reviews Endocrinol. 2020;16(12):717–30. · DOI
- Afonso J, Ramirez-Campillo R, Clemente FM, Büttner FC, Andrade R. The perils of misinterpreting and misusing publication Bias in meta-analyses: an education review on funnel plot-based methods. Sports Med. 2024;54(2):257–69. · DOI · Paper page
- Pei Y, Ke W, Lu J, Lin Y, Zhang Z, Peng Y, et al. Safety event outcomes and glycemic control with a hybrid closed-loop system used by Chinese adolescents and adults with type 1 diabetes mellitus. Diabetes Technol Ther. 2023;25(10):718–25. · DOI
Cited by
Diabetic gastroparesis: pathophysiology and impact on insulin timing choices
Galeano, F., Tumminia, A., Oteri, V., Le Moli, R., Piticchio, T., Scilletta, S., Di Marco, M., Di Pino, A., & Frasca, F. (2026) · Endocrine · doi:10.1007/s12020-026-04693-6
“Although these systems are under active investigation, prospective validation specifically in patients with DGP remains lim - ited, and their effectiveness in this setting requires further study [171].”
Digital Management of Early-Onset Type 2 Diabetes: Empowerment, Challenges, and Future Outlook
Guo, L.-J., Low, K.-S., Tae, S.-K., & Lim, L.-L. (2026) · Current Diabetes Reports · doi:10.1007/s11892-026-01633-6
Metadata
- Authors
- Wang, X., Si, J., Li, Y., Tse, P., Zhang, G., Wang, X., Ren, J., Xu, J., Sun, J., & Yao, X.
- Venue
- Diabetology & Metabolic Syndrome
- Published
- 2025-06-23
- Volume
- 17
- Issue
- 1
- ISSN
- 1758-5996
- Cited by
- 33
- References
- 27
- Language
- en
- Licence
- creativecommons.org/licenses/by-nc-nd/4.0 (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0 (vor)
- Funders
- Research Grant Council of Hong Kong (CityU 11307220)
- Shenzhen Basic Research Program (JCYJ20240813153107010)
- IDM Project from City University of Hong Kong (9229501-14-YX)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effectiveness and safety of AI-driven closed-loop systems in diabetes management: a systematic review and meta-analysis. https://app.cochat.ai/papers/10.1186/s13098-025-01819-0
- The paper
- Wang, X., Si, J., Li, Y., Tse, P., Zhang, G., Wang, X., Ren, J., Xu, J., Sun, J., & Yao, X. (2025). Effectiveness and safety of AI-driven closed-loop systems in diabetes management: a systematic review and meta-analysis. Diabetology & Metabolic Syndrome. https://doi.org/10.1186/s13098-025-01819-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.